Association between periodontitis and severity of COVID‐19 infection: A case–control study. (15th February 2021)

• Record Type: Journal Article
• Authors: Marouf, Nadya; Cai, Wenji; Said, Khalid N.; Daas, Hanin; Diab, Hanan; Chinta, Venkateswara Rao; Hssain, Ali Ait; Nicolau, Belinda; Sanz, Mariano; Tamimi, Faleh
• Is Part Of: Journal of clinical periodontology. Volume 48:Number 4(2021)
• Page Start: 483
• Page End: 491
• Publication Date: 2021-02-15
• Subjects: Covid‐19 -- death -- ICU admissions -- periodontitis -- ventilation; Periodontics -- Periodicals; 617.6
• DOI: 10.1111/jcpe.13435
• Languages: English
• ISSNs: 0303-6979

Abstract

Abstract: Aim: COVID‐19 is associated with an exacerbated inflammatory response that can result in fatal outcomes. Systemic inflammation is also a main characteristic of periodontitis. Therefore, we investigated the association of periodontitis with COVID‐19 complications. Materials and Methods: A case–control study was performed using the national electronic health records of the State of Qatar between February and July 2020. Cases were defined as patients who suffered COVID‐19 complications (death, ICU admissions or assisted ventilation), and controls were COVID‐19 patients discharged without major complications. Periodontal conditions were assessed using dental radiographs from the same database. Associations between periodontitis and COVID 19 complications were analysed using logistic regression models adjusted for demographic, medical and behaviour factors. Results: In total, 568 patients were included. After adjusting for potential confounders, periodontitis was associated with COVID‐19 complication including death (OR = 8.81, 95% CI 1.00–77.7), ICU admission (OR = 3.54, 95% CI 1.39–9.05) and need for assisted ventilation (OR = 4.57, 95% CI 1.19–17.4). Similarly, blood levels of white blood cells, D‐dimer and C Reactive Protein were significantly higher in COVID‐19 patients with periodontitis. Conclusion: Periodontitis was associated with higher risk of ICU admission, need for assisted ventilation and death of COVID‐19 patients, and with increased blood levels of biomarkers linked to worse disease outcomes.